« Return


AHCC capsule

Activates immune defence system

Ingredients: Cold dried and microcapsulated hemicellulose preparation from shiitake 400 mg, Anticaking agent E 460, Gelatin (capsule shell), Colour E 171 (capsule shell)


Ingredients in daily dosage (2 capsules):

Hemicellulose preparation from shiitake                      500 mg



More information:




1 capsule twice per day for normal daily use, for therapeutic use 4 - 8 capsules three times per day.

Contains no lactose, gluten, sweeteners or yeast.



80 capsules / 38 g



  • The main active components of Immunomax are polysaccharides (b-1-3 glucan) and glycoproteins derived from Active Hexose Correlated Compound (AHCC), which is a well-controlled substance obtained by reacting specific enzymatic reaction with basidomycetes mycelia. 


  • AHCC is effective in stimulating and enhancing the natural immunomodulatory function of the body (stimulates the production of NK cells, killer T-cells, and cytokines). 


  • AHCC is well-studied and used extensively for immuno-therapy in particular besides traditional medical treatment.


  • No reported toxicity or side effects.



1. Active hexose correlated compound enhances the immune function of mice in the hindlimb-unloading model of spaceflight conditions.
Aviles H, Belay T, Vance M, Sun B, Sonnenfeld G.
J Appl Physiol. 2004 Oct;97(4):1437-44

2. Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort study.
Matsui Y, Uhara J, Satoi S, Kaibori M, Yamada H, Kitade H, Imamura A, Takai S, Kawaguchi Y, Kwon AH, Kamiyama Y.
J Hepatol 2002 Jul;37(1):78-86

3. H-2 haplotype-dependent serum IL-12 production in tumor-bearing mice treated with various mycelial extracts.
Yagita A, Maruyama S, Wakasugi S, Sukegawa Y.
In Vivo 2002 Jan-Feb;16(1):49-54

4. [Prophylactic efficacy of a basidiomycetes preparation AHCC against lethal opportunistic infections in mice]
Ishibashi H, Ikeda T, Tansho S, Ono Y, Yamazaki M, Sato A, Yamaoka K, Yamaguchi H, Abe S.
Yakugaku Zasshi 2000 Aug;120(8):715-9

5. The use of mushroom glucans and proteoglycans in cancer treatment.
Kidd PM.
Altern Med Rev 2000 Feb;5(1):4-27

Print this page Print this page